[Therapeutic influence on the blood lipids in manifest coronary sclerosis].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004041:Dietary Fats; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D008055:Lipids / Q000097:blood*; D013464:Sulfuric Acids / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D004041:Dietary Fats; D006025:Glycosaminoglycans; D008055:Lipids; D013464:Sulfuric Acids; D002784:Cholesterol
Influencição terapêutica dos lípides séricos em esclerose coronária manifesta.